Showing 1 - 8 results of 8 for search 'Zan Teng', query time: 0.04s
Refine Results
-
1
Efficacy and safety of first-line treatments for advanced hepatocellular carcinoma patients: a systematic review and network meta-analysis by Jingyi Li, Jingyi Li, Jingyi Li, Jingyi Li, Bowen Yang, Bowen Yang, Bowen Yang, Bowen Yang, Zan Teng, Zan Teng, Zan Teng, Zan Teng, Yunpeng Liu, Yunpeng Liu, Yunpeng Liu, Yunpeng Liu, Danni Li, Danni Li, Danni Li, Danni Li, Xiujuan Qu, Xiujuan Qu, Xiujuan Qu, Xiujuan Qu
Published 2024-09-01
Article -
2
Pan-cancer immunogenic death analysis identifies key roles of CXCR3 and CCL18 in hepatocellular carcinoma by Jia Guo, Xin Sun, Guowei Pan, Ce Li, Xin He, Xiaofang Che, Zan Teng, Xiujuan Qu, Yunpeng Liu, Bowen Yang
Published 2024-03-01
Article -
3
Genetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis by Ruichuan Shi, Yu Cheng, Jin Wang, Na Song, Ying Chen, Zan Teng, Ling Xu, Yunpeng Liu, Xiaotian Zhao, Qiuxiang Ou, Peng Yang, Rui Ma, Yiting Sun, Jinglei Qu, Xiujuan Qu
Published 2025-01-01
Article -
4
Construction of the prognostic model for small‐cell lung cancer based on inflammatory markers: A real‐world study of 612 cases with eastern cooperative oncology group performance s... by Chang Liu, Bo Jin, Yunpeng Liu, Ouyang Juhua, Bowen Bao, Bowen Yang, Xiuming Liu, Ping Yu, Ying Luo, Shuo Wang, Zan Teng, Na Song, Jinglei Qu, Jia Zhao, Ying Chen, Xiujuan Qu, Lingyun Zhang
Published 2023-04-01
Article -
5
A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study by Na Song, Na Song, Yuee Teng, Yuee Teng, Jing Shi, Jing Shi, Zan Teng, Zan Teng, Bo Jin, Bo Jin, Jinglei Qu, Jinglei Qu, Lingyun Zhang, Lingyun Zhang, Ping Yu, Ping Yu, Lei Zhao, Lei Zhao, Jin Wang, Jin Wang, Aodi Li, Aodi Li, Linlin Tong, Linlin Tong, Shujie Jiang, Shujie Jiang, Yang Liu, Yang Liu, Liusong Yin, Xiaoling Jiang, Tie Xu, Jian Cui, Xiujuan Qu, Xiujuan Qu, Yunpeng Liu, Yunpeng Liu
Published 2024-11-01
Article -
6
Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II stud... by Yu Cheng, Zan Teng, Yanqiao Zhang, Bo Jin, Zhendong Zheng, Li Man, Zhenghua Wang, Yuee Teng, Ping Yu, Jing Shi, Ying Luo, Ying Wang, Jingdong Zhang, Huijuan Zhang, Jiwei Liu, Hao Chen, Jiawen Xiao, Lei Zhao, Lingyun Zhang, Yu Jiang, Ying Chen, Jian Zhang, Chang Wang, Sa Liu, Jinglei Qu, Xiujuan Qu, Yunpeng Liu
Published 2024-09-01
Article -
7
Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms by Feng Jiao, Jiujie Cui, Deliang Fu, Qi Li, Zheng Wu, Zan Teng, Hongmei Zhang, Jun Zhou, Zhihong Zhang, Xiaobing Chen, Yuhong Zhou, Yixiong Li, Yiping Mou, Renyi Qin, Yongwei Sun, Gang Jin, Yuejuan Cheng, Jian Wang, Gang Ren, Jiang Yue, Guangxin Jin, Xiuying Xiao, Liwei Wang, on behalf of Pancreatic Tumor Group, Society of Oncology, Chinese Medical Association, Yuanyuan Ji
Published 2023-10-01
Article -
8
The real-world study of the clinical characteristics, diagnosis, and treatment of advanced pancreatic cancer in China by Jiujie Cui, Qihan Fu, Xiaobing Chen, Yanling Wang, Qi Li, Feng Wang, Zhihua Li, Guanghai Dai, Yusheng Wang, Hongmei Zhang, Houjie Liang, Jun Zhou, Liu Yang, Fenghua Wang, Leizhen Zheng, Xiaofeng Chen, Ping Gong, Jiang Liu, Ying Yuan, Lin Wang, Yuejuan Cheng, Jun Zhang, Yuhong Zhou, Weijian Guo, Xianbao Zhan, Zhengyun Zou, Da Li, Shan Zeng, Enxiao Li, Zhiwei Li, Zan Teng, Dan Cao, Jie Kan, Jianping Xiong, Ming Quan, Jiayu Yao, Haiyan Yang, Liwei Wang
Published 2024-03-01
Article